Description |
transforming growth factor beta receptor 2 |
platelet derived growth factor receptor alpha |
Image |
|
|
GO Annotations |
Cellular Component |
|
|
Molecular Function |
|
|
Biological Process |
|
|
Pathways |
|
|
Drugs |
|
|
Diseases |
|
|
GWAS |
- Breast cancer ( 29059683 23535729)
- Cellular nuclear factor (erythroid-derived 2)-like 2 levels ( 30767168)
- Cognitive decline rate in late mild cognitive impairment ( 26252872)
- Estimated glomerular filtration rate ( 31152163)
- Heel bone mineral density ( 30598549)
- Metabolite levels ( 23823483)
- Migraine ( 22683712 27322543)
- Migraine - clinic-based ( 23793025)
- Night sleep phenotypes ( 27126917)
- Postprandial triglyceride response ( 32603185)
- Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab) ( 25117820)
- Systolic blood pressure ( 30224653)
- Tonometry ( 17903302)
|
|
Interacting Genes |
50 interacting genes:
ACVR1
ACVRL1
AP2B1
APP
ARHGEF6
ARHGEF7
CCNB1
CCNB2
CD44
CDK1
CLU
CTNNB1
DAB2
DAXX
DYNLT4
EIF3I
ENG
FANCC
GOPC
KCNK18
MAP2K1
NRP1
OSR1
PAK1
PDGFRA
PIK3R1
PIK3R2
PML
PPP2CB
PSMD14
RCVRN
SMAD3
SMAD4
SMAD7
SNX6
STRAP
TDGF1
TERT
TGFB1
TGFB1I1
TGFB2
TGFB3
TGFBR1
TGFBR3
TGFBRAP1
TRAP1
TRMO
TSSK1B
ZFYVE9
ZNF510
|
68 interacting genes:
AKT1
ALB
ARNT
AURKA
BECN1
CAV1
CAV3
CBL
CCND2
CD244
CD44
CDK4
CDK6
CDKN2A
CDKN2B
CDKN2C
CRK
CRKL
EGFR
EPHA2
ERBB2
ERBB3
FBXO25
FGFR4
FZR1
GRB14
GRM1
HGF
ITGAV
ITGB3
JAK1
KASH5
KDELR2
LATS2
MAP2K5
MYC
NF2
PDGFA
PDGFB
PDGFC
PDGFRB
PIK3CA
PIK3R1
PLCG1
PLPP6
PRMT5
PTPN11
RAF1
RAPGEF1
SHB
SHF
SLC9A3R1
SMURF1
SNX2
SNX4
SNX6
SPOCK1
SRPK1
STAT1
STAT3
STAT5A
STAT5B
STK11
TERT
TGFBR2
TP53
TTYH2
ULBP2
|
Entrez ID |
7048 |
5156 |
HPRD ID |
01823 |
01429 |
Ensembl ID |
ENSG00000163513
|
ENSG00000134853
|
Uniprot IDs |
A3QNQ0
D2JYI1
P37173
|
P16234
|
PDB IDs |
1KTZ
1M9Z
1PLO
2PJY
3KFD
4P7U
4XJJ
5E8V
5E8Y
5E91
5E92
5QIN
5TX4
5TY4
|
1GQ5
5GRN
5K5X
6A32
6JOI
6JOJ
6JOK
6JOL
|
Enriched GO Terms of Interacting Partners? |
|
|
Tagcloud ? |
|
|
Tagcloud (Difference) ? |
|
|
Tagcloud (Intersection) ? |
|